Biblio

Export 3138 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
C. B. Malpas, Saling, M. M., Velakoulis, D., Desmond, P., Hicks, R. J., Zetterberg, H., Blennow, K., and O'Brien, T. J., Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type., J Alzheimers Dis, vol. 62, no. 1, pp. 417-427, 2018.
G. P. Paraskevas, Kasselimis, D., Kourtidou, E., Constantinides, V., Bougea, A., Potagas, C., Evdokimidis, I., and Kapaki, E., Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia., J Alzheimers Dis, vol. 55, no. 4, pp. 1453-1461, 2017.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team., J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
M. Bjerke and Engelborghs, S., Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis., J Alzheimers Dis, vol. 62, no. 3, pp. 1199-1209, 2018.
A. Rivero-Santana, Ferreira, D., Perestelo-Pérez, L., Westman, E., Wahlund, L. - O., Sarría, A., and Serrano-Aguilar, P., Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors., J Alzheimers Dis, vol. 55, no. 2, pp. 625-644, 2017.
L. Parnetti and Eusebi, P., Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment., J Alzheimers Dis, vol. 64, no. s1, pp. S281-S287, 2018.
L. Calderón-Garcidueñas, Avila-Ramírez, J., Calderón-Garcidueñas, A., González-Heredia, T., Acuña-Ayala, H., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Cortés-González, V., Martínez-Martínez, L., García-Pérez, M. Alberto, Reis, J., Mukherjee, P. S., Torres-Jardón, R., and Lachmann, I., Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents., J Alzheimers Dis, vol. 54, no. 2, pp. 597-613, 2016.
S. Abu-Rumeileh, Mometto, N., Bartoletti-Stella, A., Polischi, B., Oppi, F., Poda, R., Stanzani-Maserati, M., Cortelli, P., Liguori, R., Capellari, S., and Parchi, P., Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study., J Alzheimers Dis, vol. 66, no. 2, pp. 551-563, 2018.
A. Kimura, Yoshikura, N., Hayashi, Y., and Inuzuka, T., Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 581-588, 2018.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
A. Arighi, Di Cristofori, A., Fenoglio, C., Borsa, S., D'Anca, M., Fumagalli, G. Giulio, Locatelli, M., Carrabba, G., Pietroboni, A. Margherita, Ghezzi, L., Carandini, T., Colombi, A., Scarioni, M., De Riz, M. Alessandra, Serpente, M., Rampini, P. Maria, Scarpini, E., and Galimberti, D., Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
N. P. Rocha, Toledo, A., Corgosinho, L. T. S., de Souza, L. C., Guimarães, H. C., Resende, E. P. F., Braz, N. F. T., Gomes, K. B., Silva, A. C. Simoes E., Caramelli, P., and Teixeira, A. L., Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 4, pp. 1085-1090, 2018.
P. Buchhave, Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O., Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia., Arch Gen Psychiatry, vol. 69, no. 1, pp. 98-106, 2012.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
M. Shams, Martola, J., Charidimou, A., Granberg, T., Ferreira, D., Westman, E., Wintermark, M., Iv, M., Larvie, M., Wiberg, M. Kristoffer, Kaijser, M., Forsgard, N., Zetterberg, H., Wahlund, L. - O., and Shams, S., Cerebrospinal Fluid Metals and the Association with Cerebral Small Vessel Disease., J Alzheimers Dis, vol. 78, no. 3, pp. 1229-1236, 2020.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H., Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study., J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
C. Liguori, Mercuri, N. Biagio, Nuccetelli, M., Izzi, F., Bernardini, S., and Placidi, F., Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms., J Alzheimers Dis, vol. 66, no. 3, pp. 993-999, 2018.
E. van den Berg, Nilsson, J., Kersten, I., Brinkmalm, G., de Kort, A. M., Klijn, C. J. M., Schreuder, F. H. B. M., Jäkel, L., Gobom, J., Portelius, E., Zetterberg, H., Brinkmalm, A., Blennow, K., H Kuiperij, B., and Verbeek, M. M., Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 467-475, 2023.
K. W. VanDusen, Li, Y. - J., Cai, V., Hall, A., Hiles, S., J Thompson, W., M Moseley, A., Cooter, M., Acker, L., Levy, J. H., Ghadimi, K., Quiñones, Q. J., Devinney, M. J., Chung, S., Terrando, N., Moretti, E. W., Browndyke, J. N., Mathew, J. P., and Berger, M., Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction., J Alzheimers Dis, vol. 80, no. 3, pp. 1281-1297, 2021.
A. Morrow, Panyard, D. J., Deming, Y. K., Jonaitis, E., Dong, R., Vasiljevic, E., Betthauser, T. J., Kollmorgen, G., Suridjan, I., Bayfield, A., Van Hulle, C. A., Zetterberg, H., Blennow, K., Carlsson, C. M., Asthana, S., Johnson, S. C., and Engelman, C. D., Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation., J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
C. Giuseppina Bonomi, Assogna, M., Di Donna, M. Gaia, Bernocchi, F., De Lucia, V., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. Biagio, Koch, G., Martorana, A., and Motta, C., Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum., J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.
J. Svensson, Blomqvist, M., Kettunen, P., Eckerström, C., Henricsson, M., Jonsson, M., Bjerke, M., Månsson, J. - E., and Wallin, A., Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia., J Alzheimers Dis, vol. 82, no. 2, pp. 781-790, 2021.
A. Piriz, Reyes, D., Narkhede, A., Guzman, V. A., Viqar, F., Meier, I. B., Budge, M., Mena, P., Dashnaw, S., Lee, J., Reitz, C., Gutierrez, J., Campos, L., Medrano, M., Lantigua, R., Mayeux, R., and Brickman, A. M., Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic., J Alzheimers Dis, vol. 66, no. 4, pp. 1519-1528, 2018.

Pages